Symptoms of @entity12131 often disappear around puberty. The authors recently demonstrated that this clinical remission is accompanied with @entity32 in most subjects. The discrepancy between lack of symptoms and persistent airway @entity32 suggests that perception of the symptoms is unclear. In the present study, young adults in clinical remission of @entity12131 assigned themselves a modified Borg score during @entity2710 and @entity1920 induced bronchoconstriction. Borg scores of subjects in clinical remission were compared with those of symptomatic asthmatic subjects. A marked variation in the Borg scores at a 20% fall in the forced expiratory volume in one second was found. Significant differences in Borg scores between remission @entity1 and asthmatics could not be detected. It was concluded that perception of dyspnoea, induced with @entity2710 and @entity859 challenge, is similar in young adults in clinical remission of @entity12131 compared to that of @entity1 with symptomatic @entity565 . Hence, an unclear perception seems to be an unlikely explanation for the discrepancy between lack of symptoms and ongoing @entity32 . Other factors, including both physical and psychological ones, may play a role in the apparent absence of symptoms, thereby potentially leading to undertreatment.

Dyspnoea perception during clinical remission of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity32 :: ('MESH:D007249', 'Disease') :: ['ongoing airways inflammation', 'inflammation'] @entity12131 :: ('MESH:C565292', 'Disease') :: ['atopic asthma'] @entity859 :: ('MESH:D000241', 'Chemical') :: ['adenosine'] @entity565 :: ('MESH:D001249', 'Disease') :: ['asthma'] @entity1920 :: ('CHEBI:16027', 'Chemical') :: ["adenosine-5'-monophosphate"] @entity2710 :: ('MESH:D016210', 'Chemical') :: ['methacholine']
@entity12131 :: (MESH:C565292,Disease) :: ['atopic asthma']
